<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Both electroconvulsive therapy (ECT) and paliperidone (PLP) can induce, though infrequently, severe cardiac side-effects </plain></SENT>
<SENT sid="1" pm="."><plain>Thus far, no studies are available on the cardiac safety of their co-administration </plain></SENT>
<SENT sid="2" pm="."><plain>We report on the cardiac safety of the ECT-PLP combination in nine female inpatients who underwent this treatment modality </plain></SENT>
<SENT sid="3" pm="."><plain>In a total of 83 ECT patient sessions, the ECT-PLP combination was well tolerated </plain></SENT>
<SENT sid="4" pm="."><plain>No patient exhibited any noticeable prolongation of QTc interval and no adverse cardiac events, in particular <z:hpo ids='HP_0011675'>arrhythmias</z:hpo>, were noted </plain></SENT>
</text></document>